Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Stockholders' Equity (Unaudited)

v3.22.1
Condensed Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($)
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
AOCI Attributable to Parent [Member]
Beginning balance, value at Dec. 31, 2020 $ 45,274,925 $ 9,885 $ 349,358,378 $ (304,093,338)  
Beginning balance, shares at Dec. 31, 2020   98,852,696      
Issuance of common stock, net of issuance costs 58,860,801 $ 2,539 58,858,262    
Issuance of common stock, net of issuance costs, shares   25,391,710      
Stock-based compensation expense 2,580,402   2,580,402    
Issuance of common stock upon exercise of stock options 894,799 $ 79 894,720    
Issuance of common stock upon exercise of stock options, shares   788,600      
Unrealized loss on marketable debt securities (28,765)       $ (28,765)
Net loss (16,065,168)     (16,065,168)  
Ending balance, value at Mar. 31, 2021 91,516,994 $ 12,503 411,691,762 (320,158,506) (28,765)
Ending balance, shares at Mar. 31, 2021   125,033,006      
Beginning balance, value at Dec. 31, 2021 69,108,027 $ 12,523 418,891,713 (349,733,764) (62,445)
Beginning balance, shares at Dec. 31, 2021   125,230,881      
Issuance of common stock, net of issuance costs   $ 3 3    
Issuance of common stock, net of issuance costs, shares   25,000      
Stock-based compensation expense 1,591,746   1,591,746    
Unrealized loss on marketable debt securities (107,248)       (107,248)
Net loss (9,437,242)     (9,437,242)  
Ending balance, value at Mar. 31, 2022 $ 61,155,283 $ 12,526 $ 420,483,456 $ (359,171,006) $ (169,693)
Ending balance, shares at Mar. 31, 2022   125,255,881